AKBA
Akebia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.68
+1.51%Leverage
- Debt / equity
- 2.16x
- Net debt / equity
- -4.06x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -2.94x
- Net debt / EBITDA
- 5.54x
Liquidity & coverage
- Current ratio
- 1.43x
- Quick ratio
- 1.35x
- Cash ratio
- 0.97x
- Interest coverage
- -1.90x
- EBITDA / interest
- -2.31x
- Working capital
- $68.7M
Cash & dividend
- FCF / debt
- 0.75x
- Cash flow / debt
- 0.77x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026